| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/17/2009 | US20090233380 Methods and Compositions of Conjugating Gold to Biological Molecules |
| 09/17/2009 | US20090233379 Taste Receptors Of The T1R Family From Domestic Dog |
| 09/17/2009 | US20090233375 Thermal bath systems and thermally-conductive particulate thermal bath media and methods |
| 09/17/2009 | US20090233374 Flourescent organic nanofibrils as sensory materials for explosives detection |
| 09/17/2009 | US20090233373 Multisite phosphorylated peptide (protein) recognizing compound and detection method, imaging method, alzheimer's disease diagnosing method and reagent kit using the same |
| 09/17/2009 | US20090233372 Compositions, kits and methods for determining etiology of trali and detecting patients at risk for this transfusion reaction |
| 09/17/2009 | US20090233349 Metal Nanowires With An Oxide Sheath And Production Method For Same |
| 09/17/2009 | US20090233325 Screening method of nesfatin-1-action regulating substance or nesfatin-1-like action substance with the use of receptor protein selected from the group consisting of gpr3, gpr6 and gpr12 |
| 09/17/2009 | US20090233322 Colorimetric method and reagent used for the same |
| 09/17/2009 | US20090233321 Reducing/Oxidizing Activity of Maternal Urine As Indicator of Fetal Gender Related Characteristics |
| 09/17/2009 | US20090233319 Method for Evaluating Skin Condition Using Squamous Cell Carcinoma Antigen as Marker |
| 09/17/2009 | US20090233318 Methods of assaying vaccine potency |
| 09/17/2009 | US20090233317 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy |
| 09/17/2009 | US20090233316 Protein, An Antibody and Measurement of the Protein |
| 09/17/2009 | US20090233315 Melanoma-associated antigen C2 (MAGE-C2); for provoking a cytolytic T cell response; for determining if a cell presents a Human Leukocyte Antigen(HLA) molecule on its surface; diagnostic and therapeutic assays; tumor monitoring |
| 09/17/2009 | US20090233314 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration |
| 09/17/2009 | US20090233313 Quantification and affinity characterization of antibodies for the diagnosis of disease using optical diffraction |
| 09/17/2009 | US20090233312 Methods and assays to assess cardiac risk and ischemia |
| 09/17/2009 | US20090233311 receptor binding assay; analysis and determining the level of procalcitonin in blood wherein an increased level of procalcitonin compared to healthy individuals is indicative of sepsis |
| 09/17/2009 | US20090233310 single, disposable probe tip for performing particle agglutination reactions; for the automation of high-throughput agglutination-type assays |
| 09/17/2009 | US20090233307 Methods for detection of single strand breaks in dna |
| 09/17/2009 | US20090233295 Trim59 directed diagnostics for neoplastic disease |
| 09/17/2009 | US20090233294 Uhrf1 directed diagnostics for neoplastic disease |
| 09/17/2009 | US20090233293 Ttk directed diagnostics for neoplastic disease |
| 09/17/2009 | US20090233286 Methods of diagnosis and prognosis of pancreatic cancer |
| 09/17/2009 | US20090233283 Stable compositions for nucleic acid amplification and sequencing |
| 09/17/2009 | US20090233281 Diagnostic marker for allergy |
| 09/17/2009 | US20090233275 Eotaxin-3 in eosinophilic esophagitis |
| 09/17/2009 | US20090233274 Drug development target protein and target gene, and method of screening |
| 09/17/2009 | US20090233270 Secreted and cytoplasmic tumor endothelial markers |
| 09/17/2009 | US20090233268 Detection of biomarkers and biomarker complexes |
| 09/17/2009 | US20090233017 Molecular imprinted material and inkjet recording element comprising said molecular imprinted material |
| 09/17/2009 | US20090232949 Fluorescent dye tracer method for animal feed supplement products |
| 09/17/2009 | US20090232918 Compositions and methods for controlling insects |
| 09/17/2009 | US20090232910 Biomarkers and therapeutics targets for cognitive decline |
| 09/17/2009 | US20090232909 Method for determining physiological effects of hemoglobin |
| 09/17/2009 | US20090232852 Use of outer membrane protein a (ompa) in treatment/prevention/diagnosis of infections caused by klebsiella pneumoniae and other gram-negative bacteria |
| 09/17/2009 | US20090232848 Methods for cultivating lawsonia intracellularis |
| 09/17/2009 | US20090232843 Identifying and predicting influenza variants and uses thereof |
| 09/17/2009 | US20090232822 Lung disease targets and uses thereof |
| 09/17/2009 | US20090232821 Use Of A Growth-Stimulating Protein |
| 09/17/2009 | US20090232820 Neisseria meningitidis antigens and compositions |
| 09/17/2009 | US20090232818 Prognosis and Treatment of Breast Cancer |
| 09/17/2009 | US20090232816 Il-1 eta dna and polypeptides |
| 09/17/2009 | US20090232812 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 09/17/2009 | US20090232809 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/17/2009 | US20090232808 Molecules and chimeric molecules thereof |
| 09/17/2009 | US20090232802 Compositions and methods for the treatment of natural killer cell related diseases |
| 09/17/2009 | US20090232801 Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof |
| 09/17/2009 | US20090232800 E1-minus adenoviruses and use thereof |
| 09/17/2009 | US20090232799 Antibodies that bind urokinase-type plasminogen activator and epitopes therefor |
| 09/17/2009 | US20090232797 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/17/2009 | US20090232794 Modulators of neuronal regeneration |
| 09/17/2009 | US20090232778 Methods and Compositions for Hair Growth |
| 09/17/2009 | US20090232777 Expansion and Differentiation of Mesenchymal Stem Cells |
| 09/17/2009 | US20090232740 Methods of detecting cancer cells and use of same for diagnosing and monitoring treatment of the disease |
| 09/17/2009 | US20090232736 Dual specificity antibodies and methods of making and using |
| 09/17/2009 | US20090232732 PRO108 Antibody Compositions and Methods of Use and Use of PRO108 to Assess Cancer Risk |
| 09/17/2009 | US20090232705 Automatic analyzer |
| 09/17/2009 | US20090232704 Multiple-Sample Automatic Processing System and Multiple-Sample Automatic Processing Method |
| 09/17/2009 | US20090232703 Methods and systems for monitoring sterilization status |
| 09/17/2009 | US20090231980 Optical disc assemblies for performing assays |
| 09/17/2009 | US20090230302 Electron Transfer Dissociation for Biopolymer Sequence Analysis |
| 09/17/2009 | US20090230300 Rapid detection of volatile organic compounds for identification of bacteria in a sample |
| 09/17/2009 | US20090229383 Apparatus for Determining the Filterability of Fluids, In Particular of Transmission Oils |
| 09/17/2009 | US20090229346 Systems and method for capture substrates |
| 09/17/2009 | US20090229342 Hybrid plasmon damping sensor |
| 09/17/2009 | DE202009009129U1 Permeationszelle für die in-vitro-Untersuchung der Hautpermeation von pharmazeutischen Wirkstoffen Permeation cell for the in vitro study of skin permeation of active pharmaceutical ingredients |
| 09/17/2009 | DE102008014029A1 Determining microbial contamination of water, comprises supplying sample in a reaction chamber, adding determined quantity of nutrient solution, which is a minimal medium, and intermixing the mixture of nutrient solution and water sample |
| 09/17/2009 | DE102008013754A1 Messverfahren und Messanordnung zur Bestimmung des Gehalts eines chemischen Elements oder eines anderen Wasserqualitätsparameters in Frisch- oder Abwasser Measurement methods and apparatus for determining the content of a chemical element or other water quality parameter in fresh water or wastewater |
| 09/17/2009 | CA2718878A1 Compositions and methods for the therapy and diagnosis of cytomegalovirus |
| 09/17/2009 | CA2718404A1 Labeled reactants and their uses |
| 09/17/2009 | CA2718382A1 C2orf18 as target gene for cancer therapy and diagnosis |
| 09/17/2009 | CA2718293A1 Dna repair proteins associated with triple negative breast cancers and methods of use thereof |
| 09/17/2009 | CA2718251A1 Copd biomarker signatures |
| 09/17/2009 | CA2718245A1 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation. |
| 09/17/2009 | CA2718229A1 Cervical screening algorithms |
| 09/17/2009 | CA2718201A1 Device and method for the contactless detection of characteristics of continuously delivered translucent products |
| 09/17/2009 | CA2718167A1 Particle agglutination in a pipette tip |
| 09/17/2009 | CA2718126A1 In vitro method to determine whether a drug candidate active against a target protein is active against a variant of said protein |
| 09/17/2009 | CA2718032A1 Method for generating primate cardiovascular progenitor cells for clinical use from primate embryonic stem cells or embryonic-like state cells, and their applications |
| 09/17/2009 | CA2717996A1 Method for detecting and quantifying a molecule including at least one proton group on a solid substrate |
| 09/17/2009 | CA2717918A1 Method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) and related technologies |
| 09/17/2009 | CA2717614A1 Antibodies with enhanced adcc function |
| 09/17/2009 | CA2717308A1 Method for the purification of biological macromolecules |
| 09/17/2009 | CA2717221A1 Reagents and methods for detecting influenza virus proteins |
| 09/17/2009 | CA2715034A1 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 09/17/2009 | CA2715033A1 Immuno-based botulinum toxin serotype a activity assays |
| 09/17/2009 | CA2713544A1 Fluorescent dye tracer method for animal feed supplement products |
| 09/17/2009 | CA2713411A1 Method for in vitro detection and/or quantification and/or identification of infectious compounds in a biological material |
| 09/17/2009 | CA2713155A1 Method for in vitro detection and/or quantification and/or identification of bacteria in a biological material |
| 09/17/2009 | CA2711867A1 Use of a protein or nitrated peptide sequence for implementing a diagnosis method |
| 09/17/2009 | CA2658074A1 Functional pigmented skin equivalent |
| 09/16/2009 | EP2101178A1 Use of Procalcitonin (PCT) in prognosis following acute coronary syndromes |
| 09/16/2009 | EP2101177A1 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (EBV) reactivation |
| 09/16/2009 | EP2101176A1 Diagnosis of and vaccination against Aspergillus fumigatus |
| 09/16/2009 | EP2101175A1 High order nanostructure and sensor and use of same |
| 09/16/2009 | EP2101174A1 Solid phases optimized for chemiluminescent detection |
| 09/16/2009 | EP2101173A1 In vitro method to determine whether a drug candidate active against a target protein is active against a variant of said protein |
| 09/16/2009 | EP2101171A1 Taste recognizing device and taste recognizing system using same |